Marina Richardson, PhD, MSc

Associate Director, Health Technology Assessment Methods and Health Economics

Marina is ICER’s Associate Director of Health Technology Assessment (HTA) Methods and Health Economics. In her role, Marina leads and oversees the development of economic models to inform pricing and reimbursement decision-making and executes opportunities to enhance ICER’s methodology in HTA and Health Economics. Prior to joining ICER, Marina led and contributed to reimbursement review reports and recommendations at Canada’s Drug Agency (CDA-AMC), formerly CADTH. Marina has led initiatives to streamline the biosimilar review process, identify opportunities to improve the deliberative appraisal process, and explore opportunities to enhance patient engagement in cost-effectiveness analysis.

Marina is an active contributor to the field including as a Deputy Editor for the International Journal of Technology Assessment in Health Care (IJTAHC), as a member of the Ontario Immunization Advisory Committee (OIAC) in Ontario, Canada, and as a co-chair of the International Scientific Program Committee for Health Technology Assessment International (HTAi) 2025. Marina completed an MSc in Epidemiology and Biostatistics at Western University, and a PhD in Health Services Research (HTA emphasis) at the University of Toronto in Canada. In her spare time, Marina enjoys connecting with family, friends, and colleagues, playing sports, spending time at the cottage, and traveling.